Eledon Pharmaceuticals Inc ELDN

‎$‎3.300.10(3.13%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Price Target

6.00

Based on analysts who covered ELDN

Invest in Eledon Pharmaceuticals Inc
Today

Create an eToro account to buy ELDN stock on a secure, user-friendly, multi-asset trading platform.

Eledon Pharmaceuticals Inc ELDN

Buy ELDN

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

China Tobacco International HK Co Ltd

‎$‎31.80

+3.58%

PII

Polaris Industries Inc

‎$‎47.88

-16.72%

MAX

*Past performance is not an indication of future results

Jump to:

About ELDN >
How to Buy? >
Top Guides >

The Eledon Pharmaceuticals Inc share price is stable this week.

The Eledon Pharmaceuticals Inc price today is ‎$‎3.30, a ‎3.13‎% change in the last 24 hours and ‎0‎% in the past week. Eledon Pharmaceuticals Inc price changed by ‎0‎% in the past year.

ELDN Key Metrics

Market Cap

Day’s Range

‎$‎3.19 - ‎$‎3.42

52W Range

‎$‎1.44 - ‎$‎3.42

Average Volume (3M)

Price-Earnings Ratio

Revenue

Dividend (Yield)

Prev Close

‎$‎3.3

EPS

Beta

How can I buy Eledon Pharmaceuticals Inc stocks?

To purchase Eledon Pharmaceuticals Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Eledon Pharmaceuticals Inc (ELDN) page and place an order to buy Eledon Pharmaceuticals Inc.

Buy ELDN

Looking for more information? Check out our guide on Academy.

What Is Eledon Pharmaceuticals Inc?

Eledon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company headquartered in the United States. It focuses on developing novel therapies aimed at addressing serious inflammatory and fibrotic diseases. The company's primary aim is to improve patient outcomes globally by targeting significant unmet medical needs.

Operating within the biotechnology sector, Eledon Pharmaceuticals Inc specifically focuses on developing product candidates that target the CD40L pathway. This approach is intended to offer potential treatment solutions for conditions such as organ transplant rejection and certain autoimmune disorders.

Monitor the ELDN share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

CEO

David-Alexandre C. Gros, MD, MBA

Employees

Founded

2004

Irvine, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Eledon Pharmaceuticals Inc
Today

Create an eToro account to buy ELDN stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Eledon Pharmaceuticals Inc stock?

The current price of ELDN is ‎$‎3.30.

What is Eledon Pharmaceuticals Inc’s stock future price target?

The average price target for Eledon Pharmaceuticals Inc is ‎$‎6.00. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Eledon Pharmaceuticals Inc?

Analysts offer forecasts for Eledon Pharmaceuticals Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Eledon Pharmaceuticals Inc?

The market capitalisation of Eledon Pharmaceuticals Inc is (The data is unavailable right now)

Is Eledon Pharmaceuticals Inc stock buy, sell or hold?

Based on 2 analysts offering recommendations for ELDN in the last 3 months, the overall consensus is .

Daily Movers

Explore the biggest stocks movers on the market.